NF-κB and the link between inflammation and cancer

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Nuclear factor-kappa B (NF-κB) is a transcription factor family central to inflammatory processes and immune responses.
• Its structural similarity to the v-Rel oncogene suggested a role in cancer development.

Purpose of the Study:

• To explore the role of NF-κB in cancer development and its therapeutic implications.
• To understand the cell-type-specific functions of NF-κB in various malignancies.

Main Methods:

• Review of molecular cloning and genetic mutation data related to NF-κB.
• Analysis of NF-κB activation mechanisms in different cancer types, including lymphoid malignancies and carcinomas.
• Examination of NF-κB's role in the tumor microenvironment and cancer cell signaling.

Main Results:

• Direct oncogenic mutations in NF-κB genes are infrequent, primarily observed in some lymphoid malignancies.
• Most lymphoid malignancies exhibit NF-κB activation through upstream signaling components.
• NF-κB activation is common in carcinomas, often induced by inflammatory cytokines in the tumor microenvironment.
• NF-κB exhibits cell-type-specific functions, promoting cancer cell survival and tumor microenvironment inflammation.

Conclusions:

• NF-κB plays a dual role in cancer, supporting cancer cell survival and driving tumor-promoting inflammation.
• The complex biology and cell-specific actions of NF-κB present challenges for targeted cancer therapies.